This document provides supplementary guidance on specific topics for the allergenicity risk assessment of genetically modified plants. In particular, it supplements general recommendations outlined in previous EFSA GMO Panel guidelines and Implementing Regulation (EU) No 503/2013. The topics addressed are non-IgE-mediated adverse immune reactions to foods, in vitro protein digestibility tests and endogenous allergenicity. New scientific and regulatory developments regarding these three topics are described in this document. Considerations on the practical implementation of those developments in the risk assessment of genetically modified plants are discussed and recommended, where appropriate. (C) 2017 European Food Safety Authority. EFSA J...
Technical advances in biotechnology lead to a rising number of genetically modified plants and deriv...
There is a need to assess the safety of foods deriving from genetically modified (GM) crops, includi...
The current allergenicity assessment of novel proteins is based on the EFSA GMO guidance. Recently, ...
This document provides supplementary guidance on specific topics for the allergenicity risk assessme...
Resumen del trabajo presentado a la 3rd International ImpARAS Conference, celebrada en Helsingør (Di...
According to EU legislation, genetically modified plants (GM plants) should follow a scientific asse...
According to EU regulation, genetically modified (GM) plants considered to be allergenic have to be ...
The pre-market safety assessment of foods derived from genetically modified crops is carried out acc...
Genetically modified (GM) plants are increasingly used for food production and industrial applicatio...
The safety of food produced from genetically engineered (GE) crops is assessed for potential risks o...
The weight-of-evidence, case-by-case approach is considered the most appropriate way of assessing th...
Allergenicity assessment of genetically modified (GM) plants is one of the key pillars in the safety...
To solve the future food insecurity problem, alternative and sustainable protein sources (e.g. insec...
Based on experience and scientific advancements over the past two decades, a revised approach for th...
The current allergenicity assessment of novel proteins is based on the EFSA GMO guidance. Recently, ...
Technical advances in biotechnology lead to a rising number of genetically modified plants and deriv...
There is a need to assess the safety of foods deriving from genetically modified (GM) crops, includi...
The current allergenicity assessment of novel proteins is based on the EFSA GMO guidance. Recently, ...
This document provides supplementary guidance on specific topics for the allergenicity risk assessme...
Resumen del trabajo presentado a la 3rd International ImpARAS Conference, celebrada en Helsingør (Di...
According to EU legislation, genetically modified plants (GM plants) should follow a scientific asse...
According to EU regulation, genetically modified (GM) plants considered to be allergenic have to be ...
The pre-market safety assessment of foods derived from genetically modified crops is carried out acc...
Genetically modified (GM) plants are increasingly used for food production and industrial applicatio...
The safety of food produced from genetically engineered (GE) crops is assessed for potential risks o...
The weight-of-evidence, case-by-case approach is considered the most appropriate way of assessing th...
Allergenicity assessment of genetically modified (GM) plants is one of the key pillars in the safety...
To solve the future food insecurity problem, alternative and sustainable protein sources (e.g. insec...
Based on experience and scientific advancements over the past two decades, a revised approach for th...
The current allergenicity assessment of novel proteins is based on the EFSA GMO guidance. Recently, ...
Technical advances in biotechnology lead to a rising number of genetically modified plants and deriv...
There is a need to assess the safety of foods deriving from genetically modified (GM) crops, includi...
The current allergenicity assessment of novel proteins is based on the EFSA GMO guidance. Recently, ...